<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03818971</url>
  </required_header>
  <id_info>
    <org_study_id>RIPH 2018-02</org_study_id>
    <nct_id>NCT03818971</nct_id>
  </id_info>
  <brief_title>Study of Retinal Function Using Electroretinogram in Regular Alcohol Users</brief_title>
  <acronym>ERICA</acronym>
  <official_title>Study of Retinal Function Using Electroretinogram in Regular Alcohol Users</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Psychothérapique de Nancy</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Psychothérapique de Nancy</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Alcohol is a major public health problem and its neurotoxic effects are, among other things,&#xD;
      responsible for altering the functioning of cerebral neurotransmission pathways.&#xD;
&#xD;
      The retina is an anatomical and developmental extension of the central nervous system. It is&#xD;
      composed of several layers of retinal neurons that share similar anatomical and functional&#xD;
      properties with brain neurons. Retinal neurons are notably equipped with a complex system of&#xD;
      neurotransmission constituted by the main neurotransmitters that are involved in the central&#xD;
      effects of alcohol: glutamate, dopamine, serotonin ... The retina is used here as a site of&#xD;
      indirect investigation for abnormal central neurotransmission pathways following regular&#xD;
      alcohol use. It is recognized to date as a good site for investigating central abnormalities&#xD;
      in neuropsychiatric and addictive disorders.&#xD;
&#xD;
      The objective of this project is to study the retinal function using electroretinogram (ERG)&#xD;
      in regular alcohol users to isolate potential markers of cerebral neurotransmission&#xD;
      abnormalities.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 13, 2019</start_date>
  <completion_date type="Actual">March 22, 2021</completion_date>
  <primary_completion_date type="Actual">March 22, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>mono centric study, in parallel groups, controlled, non-randomized and open</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>modification of amplitude</measure>
    <time_frame>Day 0 (=day of inclusion = the only visit of the study)</time_frame>
    <description>measured with flash electroretinogram and pattern electroretinogram / amplitude in microvolt</description>
  </primary_outcome>
  <primary_outcome>
    <measure>modification of implicite time parameters</measure>
    <time_frame>Day 0 (=day of inclusion = the only visit of the study)</time_frame>
    <description>measured with flash electroretinogram and pattern electroretinogram - implicite time in millisecond</description>
  </primary_outcome>
  <primary_outcome>
    <measure>modification of amplitude of the oscillatory potential</measure>
    <time_frame>Day 0 (=day of inclusion = the only visit of the study)</time_frame>
    <description>waves P1, P2, P3, P4 measured with flash electroretinogram - amplitude in microvolt</description>
  </primary_outcome>
  <primary_outcome>
    <measure>modification of implicit time of the oscillatory potential</measure>
    <time_frame>Day 0 (=day of inclusion = the only visit of the study)</time_frame>
    <description>waves P1, P2, P3, P4 measured with flash electroretinogram - implicite time in millisecond</description>
  </primary_outcome>
  <primary_outcome>
    <measure>modification of amplitude of the background noise</measure>
    <time_frame>Day 0 (=day of inclusion = the only visit of the study)</time_frame>
    <description>measured with the flash electroretinogram, flicker 3.0 sequence - amplitude in microvolt</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Alcohol Use Disorder</condition>
  <arm_group>
    <arm_group_label>alcohol consumption with alcohol use disorder (AUD)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>subjects with regular alcohol consumption with AUD according to the DSM 5 without any other substance use disorder (except alcohol) without psychiatric, neurologic or ophthalmologic disease in progress with a negative drug check and Breathalyzer the day of the inclusion - only one visit is planned for this study : an electroretinogram will be realized</description>
  </arm_group>
  <arm_group>
    <arm_group_label>alcohol consumption without alcohol use disorder</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>subjects with regular alcohol consumption without AUD according to the DSM 5 without any other substance use disorder without psychiatric, neurologic or ophthalmologic disease in progress with a negative drug check and Breathalyzer the day of the inclusion - only one visit is planned for this study : an electroretinogram will be realized</description>
  </arm_group>
  <arm_group>
    <arm_group_label>no alcohol consumption</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>subjects without alcohol consumption without any other substance use disorder without psychiatric, neurologic or ophthalmologic disease in progress with a negative drug check and Breathalyzer the day of the inclusion - only one visit is planned for this study : an electroretinogram will be realized</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>electroretinogram (flash, pattern and multifocal)</intervention_name>
    <description>we measured the waves a, b, oscillatory potentials, back ground noise and i for the flash ERG, the waves P50 and N95 for the pattern ERG and the P1, N1 and N2 for the multifocal ERG</description>
    <arm_group_label>alcohol consumption with alcohol use disorder (AUD)</arm_group_label>
    <arm_group_label>alcohol consumption without alcohol use disorder</arm_group_label>
    <arm_group_label>no alcohol consumption</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        For alcohol consumer with alcohol use disorder :&#xD;
&#xD;
        Inclusion Criteria:&#xD;
&#xD;
          -  aged between 18 and 35 years&#xD;
&#xD;
          -  alcohol use disorder according to the DSM 5&#xD;
&#xD;
          -  affiliation to a social security scheme&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  psychoactive substance consumption (other than alcohol)&#xD;
&#xD;
          -  psychiatric disease in progress according to the DSM 5&#xD;
&#xD;
          -  neurologic disease in progress&#xD;
&#xD;
          -  mental impairment making it difficult or impossible to participate to the study&#xD;
&#xD;
          -  major under guardianship or curatorship or under safeguarding of justice&#xD;
&#xD;
          -  pregnant women or feeding&#xD;
&#xD;
          -  people in emergency situation&#xD;
&#xD;
          -  participation to another interventional study&#xD;
&#xD;
          -  retinal disease in progress&#xD;
&#xD;
          -  chronic glaucoma&#xD;
&#xD;
          -  ophtalmic disease affecting the visual acuity&#xD;
&#xD;
          -  ocular infection in progress&#xD;
&#xD;
          -  urinary positive drug check the day of the inclusion&#xD;
&#xD;
          -  postive Breathalyser the day of the inclusion&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas SCHWITZER</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Psychothérapique de Nancy</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre Psychothérapique de Nancy</name>
      <address>
        <city>Laxou</city>
        <state>Nancy</state>
        <zip>54520</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>January 10, 2019</study_first_submitted>
  <study_first_submitted_qc>January 25, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 28, 2019</study_first_posted>
  <last_update_submitted>October 21, 2021</last_update_submitted>
  <last_update_submitted_qc>October 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>retina AND electroretinogram</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alcoholism</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

